These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 1352556

  • 1. Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.
    Costall B, Domeney AM, Farre AJ, Kelly ME, Martinez L, Naylor RJ.
    J Pharmacol Exp Ther; 1992 Jul; 262(1):90-8. PubMed ID: 1352556
    [Abstract] [Full Text] [Related]

  • 2. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF, Lesourd M, Mocaer E, Koolhaas JM.
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [Abstract] [Full Text] [Related]

  • 3. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K, Aota M, Inoue T, Matsuda R, Mihara T, Yamaji T, Ishibashi K, Matsuoka N.
    Eur J Pharmacol; 2006 Dec 28; 553(1-3):171-84. PubMed ID: 17074317
    [Abstract] [Full Text] [Related]

  • 4. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
    Millan MJ, Hjorth S, Samanin R, Schreiber R, Jaffard R, De Ladonchamps B, Veiga S, Goument B, Peglion JL, Spedding M, Brocco M.
    J Pharmacol Exp Ther; 1997 Jul 28; 282(1):148-61. PubMed ID: 9223550
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test.
    Grundmann O, Nakajima J, Seo S, Butterweck V.
    J Ethnopharmacol; 2007 Apr 04; 110(3):406-11. PubMed ID: 17101250
    [Abstract] [Full Text] [Related]

  • 10. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
    Hamon M, Fattaccini CM, Adrien J, Gallissot MC, Martin P, Gozlan H.
    J Pharmacol Exp Ther; 1988 Aug 04; 246(2):745-52. PubMed ID: 2457083
    [Abstract] [Full Text] [Related]

  • 11. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
    Dawson LA, Hughes ZA, Starr KR, Storey JD, Bettelini L, Bacchi F, Arban R, Poffe A, Melotto S, Hagan JJ, Price GW.
    Neuropharmacology; 2006 Jun 04; 50(8):975-83. PubMed ID: 16581092
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of buspirone and related compounds on suppressed operant responding in rats.
    Sanger DJ.
    J Pharmacol Exp Ther; 1990 Aug 04; 254(2):420-6. PubMed ID: 1974634
    [Abstract] [Full Text] [Related]

  • 17. Effect of repeated ipsapirone treatment on hippocampal excitatory synaptic transmission in the freely behaving rat: role of 5-HT1A receptors and relationship to anxiolytic effect.
    Xu L, Anwyl R, De Vry J, Rowan MJ.
    Eur J Pharmacol; 1997 Mar 26; 323(1):59-68. PubMed ID: 9105877
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.
    Griebel G, Perrault G, Sanger DJ.
    Psychopharmacology (Berl); 1998 Jul 26; 138(1):55-66. PubMed ID: 9694527
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT2A/2C antagonist anxiolytics. I. Antipunishment effects in the pigeon.
    Kleven MS, Koek W.
    J Pharmacol Exp Ther; 1996 Feb 26; 276(2):388-97. PubMed ID: 8632301
    [Abstract] [Full Text] [Related]

  • 20. Alteration of 5-HT1A receptor binding sites following chronic treatment with ipsapirone measured by quantitative autoradiography.
    Fanelli RJ, McMonagle-Strucko K.
    Synapse; 1992 Sep 26; 12(1):75-81. PubMed ID: 1357765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.